© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Correspondence |
The economic cost of invasive pneumococcal disease and the potential for reduction by vaccination in an adult population in South Yorkshire
| The first 10% of the full text of this article appears below. |
Sir,
Risk factors for invasive pneumococcal disease (IPD) permit targeted immunization of adults with a 23-valent capsular polysaccharide of moderate efficacy.1,2 We identified 553 adult cases of IPD in Sheffield between 1992 and 2000, identified all 230 cases admitted to the Royal Hallamshire Hospital, Sheffield, and retrospectively estimated the economic costs and potential vaccine impact on
Department of Microbiology and Department of Infection and Tropical Medicine Sheffield Teaching Hospitals Trust Department of Infection and Tropical Medicine Sheffield Teaching Hospitals Trust Health Economics and Decision Science School of Health and Related Research University of Sheffield Department of Infection and Tropical Medicine Sheffield Teaching Hospitals Trust and Division of Genomic Medicine University of Sheffield Medical School Sheffield
email: d.h.dockrell@sheffield.ac.uk